DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020950
» See Plans and Pricing
The generic ingredient in DUONEB is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 020950
Tradename: | DUONEB |
Applicant: | Mylan Speciality Lp |
Ingredient: | albuterol sulfate; ipratropium bromide |
Patents: | 1 |
Paragraph IV (Patent) Challenges for 020950
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
DUONEB | SOLUTION;INHALATION | albuterol sulfate; ipratropium bromide | 020950 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
Approval Date: | Mar 21, 2001 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Dec 28, 2021 | Product Flag? | Substance Flag? | Delist Request? |
Complete Access Available with Subscription